FDA Human Factors Guidance 2026: What 510(k) and PMA Teams Need to Know

This episode provides a detailed analysis of the U.S. FDA's final guidance on 'Content of Human Factors Information in Medical Device Marketing Submissions,' issued on August 3, 2026. We break down the specific human factors and usability engineering documentation now required for premarket submissions like 510(k)s and PMAs. Learn what the FDA expects to see in your HFE report, who is affected by these changes, and practical steps your team can take to ensure a compliant and successful submission. Key Questions: - What are the key requirements in the FDA's 2026 Human Factors guidance? - How does this guidance impact manufacturers preparing 510(k) and PMA submissions? - What are the three main components of a Human Factors Engineering report expected by the FDA? - Which types of premarket submissions are covered by this new guidance? - Why is early integration of HFE critical for the product development lifecycle? - What practical steps can regulatory teams take to prepare for these new requirements? - How can a well-structured HFE report streamline the FDA review process? - What are the risks of failing to adequately address human factors in a submission? Sources: - https://www.fda.gov/medical-devices/news-events-medical-devices/cdrh-new-news-and-updates How Pure Global can help: Pure Global helps MedTech and IVD companies navigate complex regulatory landscapes like the FDA's new Human Factors guidance. Our experts develop efficient regulatory strategies and use advanced AI to compile, manage, and submit technical dossiers for 510(k)s, PMAs, and other global submissions. We act as your local representative and provide continuous regulatory monitoring to ensure your products remain compliant. Whether you are a startup or a multinational enterprise, Pure Global streamlines your path to market. Visit us at https://pureglobal.com, contact us at [email protected], or explore our free AI tools and device database at https://pureglobal.ai.